However, a growing number of publications assessing the clinical presentation and histological characteristics of patients affected by ALK-RCC have been published in recent years (Figure 1) [1,6], mainly as case reports and case series [5]. The gene discussed is ALK; the disease is renal cell adenocarcinoma.